Indaptus Therapeutics, Inc. Common Stock INDP

$3.55 -9.67% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-10 View →
8-K 8-K 2026-09-04 View →
424B5 424B5 2026-09-04 View →
8-K 8-K 2026-09-01 View →
424B5 424B5 2026-08-31 View →
S-3 S-3 2026-08-17 View →
10-Q 10-Q 2026-08-13 View →
8-K 8-K 2026-08-13 View →
DEF 14A DEF 14A 2026-07-16 View →
S-3 S-3 2026-06-26 View →
8-K 8-K 2026-06-24 View →
8-K 8-K 2026-06-05 View →
10-Q 10-Q 2026-05-15 View →
8-K 8-K 2026-05-15 View →
8-K 8-K 2026-04-23 View →
8-K 8-K 2026-04-03 View →
8-K 8-K 2026-03-24 View →
4 OWNERSHIP DOCUMENT 2026-03-24 View →
10-K 10-K 2026-03-17 View →
4 4 2026-02-27 View →
8-K 8-K 2026-02-27 View →
4 4 2026-02-13 View →
8-K 8-K 2026-02-12 View →
4 4 2026-01-22 View →
4 4 2026-01-22 View →
DEF 14A DEF 14A 2026-01-21 View →
8-K 8-K 2026-01-20 View →
8-K 8-K 2026-01-08 View →
8-K 8-K 2026-01-02 View →
4 4 2025-12-29 View →
4 4 2025-12-29 View →
4 4 2025-12-29 View →
4 4 2025-12-29 View →
8-K 8-K 2025-12-23 View →
10-Q 10-Q 2025-11-12 View →
8-K 8-K 2025-11-12 View →
8-K 8-K 2025-09-04 View →
S-1 S-1 2025-09-02 View →
424B5 424B5 2025-09-02 View →
S-3 S-3 2025-08-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$3.55
Market Cap
$523.64 million
52-Week Range
$0.92 – $8.57
Average Volume
1.45 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.